Total Funding
61
68
Total FundingVenture - Series Unknown raised
Growth Score 61 in past quarter
-22 pts
Heat Score 68 in past quarter
8 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
4322
Mission Bio develops only single-cell multi-omics platform integrating genotype and phenotype for cancer research and biomarker development.
- Todd Druley: Chief Medical OfficerPast Role: CelLBxHealth, Chief Medical Officer
Adam Sciambi: Co-Founder and VP of TechnologyPast Role: Mission Bio, Co-Founder & Director of Engineering
About the Company
Mission Bio is a company that provides a single-cell multi-omics platform for cancer research. The platform allows researchers to measure single nucleotide variations, copy number variations, and protein data from the same cell. Mission Bio's solutions provide insights into clonal heterogeneity, which helps with disease progression and therapy
response.